Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Hangzhou Tigermed Consulting Co.,Ltd    300347   CNE100001KV8

HANGZHOU TIGERMED CONSULTING CO.,LTD

(300347)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on HANGZHOU TIGERMED CONSULTING CO.,LTD
03/30/21 Jahr 2020 Ergebnisveröffentlichung
05/04/21 Q1 2021 Ergebnisveröffentlichung (geplant)
08/27/21 Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant)
11/03/21 Q3 2021 Ergebnisveröffentlichung (geplant)
Past events on HANGZHOU TIGERMED CONSULTING CO.,LTD
11/26/20 | 08:00am Ausserordentliche Aktionärsversammlung
10/29/20 Q3 2020 Ergebnisveröffentlichung
08/29/20 Erstes Halbjahr 2020 Ergebnisveröffentlichung
05/12/20 | 09:00am Jahreshauptversammlung
Upcoming sector events for HANGZHOU TIGERMED CONSULTING CO.,LTD
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
02/01/21 VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Release
02/01/21 | 04:30pm VERTEX PHARMACEUTICALS INCORPORATED : FY 2020 Earnings Call
02/02/21 | 09:00am BIO-TECHNE CORPORATION : Interim 2021 Earnings Call
More events
Past sector events for HANGZHOU TIGERMED CONSULTING CO.,LTD
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
Annual publications
Annual results201520162017201820192020 (e)
Sales
M CNY
Released
Forecast
Spread
957
893
7,2%
1 175
1 181
-0,58%
1 687
1 758
-4,0%
2 301
2 288
0,55%
2 803
2 966
-5,5%

3 316
Operating income
(EBITDA)
M CNY
Released
Forecast
Spread


235
225
4,2%
449
431
4,1%
654
623
5,0%
1 132
927
22%

1 337
Operating profit
(EBIT)
M CNY
Released
Forecast
Spread
214
235
-9,1%
198
241
-18%
417
421
-1,1%
596
632
-5,8%
1 085
878
24%

910
Pre-Tax Profit
(EBT)
M CNY
Released
Forecast
Spread
220
235
-6,3%
212
247
-14%
431
453
-4,8%
606
652
-7,0%
1 089
965
13%

1 867
Net income
M CNY
Released
Forecast
Spread
156
179
-13%
141
174
-19%
301
294
2,6%
472
459
2,9%
842
733
15%

1 528
EPS
CNY
Released
Forecast
Spread
0,24
0,27
-9,5%
0,20
0,24
-18%
0,40
0,39
2,9%
0,63
0,61
3,1%
1,13
0,98
16%

1,81
Announcement Date02/29/201602/28/201702/26/201802/27/201902/28/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M CNY
Released
Forecast
Spread
694
767
-9,5%
772
936
-17%
650
788
-18%
802
874
-8,2%
848
791
7,2%

871
Operating income
(EBITDA)
M CNY
Released
Forecast
Spread

199

263








Operating profit
(EBIT)
M CNY
Released
Forecast
Spread
227
178
28%
425
263
61%
286
270
5,9%


422
205
106%

176
Pre-Tax Profit
(EBT)
M CNY
Released
Forecast
Spread
228
210
8,8%
425
294
45%
285
325
-12%


419
414
1,1%

385
Net income
M CNY
Released
Forecast
Spread
176
176
-0,17%
314
223
40%
255
266
-4,1%


319
362
-12%

332
EPS
CNY
Released
Forecast
Spread
0,23
0,22
7,2%
0,43
0,33
31%
0,34
0,28
22%
1,01
0,28
267%
0,39
0,35
12%

0,30
Announcement Date10/27/201902/28/202004/28/202008/28/202010/29/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise